Researchers at the University of Oxford are starting a new study to explore the effectiveness of the anti-tumour necrosis factor (anti-TNF) drug adalimumab as a treatment for patients with COVID-19 in the community, especially care homes.

As COVID-19 infections begin to rise again, a novel testing strategy proposed by researchers at the University of Oxford at the start of the pandemic has become urgent once again. 

Scientists from the University of Oxford's Nuffield Department of Medicine have today published their evaluation of LamPORE , a novel diagnostic platform for detecting SARS-CoV-2 RNA. It combines loop-mediated isothermal amplification with nanopore sequencing. This technology has the potential to analyse thousands of samples per day on a single instrument.  

A new online consent programme has launched for all students at the University of Oxford. The programme will help new and returning students to build their understanding of consensual sex, respect, boundaries and positive intervention.

Carbon offsetting is a widespread tool in efforts to achieve net zero emissions. But current approaches to offsetting are unlikely to deliver the types of offsets needed to achieve global climate goals. Net zero pledges from many companies, such as those recently from BP and Google, and the recent 2060 "carbon neutrality" pledge from China are likely to use offsets. But what types of offsets are acceptable and under what conditions should they be used? Launched today, The Oxford Principles for Net Zero Aligned Carbon Offsetting (or 'The Oxford Offsetting Principles '), provide guidelines to help ensure offsetting actually helps to achieve a net zero society.

New research shows that, in a head-to-head comparison of five tests used to detect COVID-19 antibodies (known as 'immunoassays'), an assay manufactured by Siemens and one developed by an academic partnership led by the University of Oxford had the most accurate results. The study is published in The Lancet Infectious Diseases.

A team of mathematical modellers and epidemiologists at Oxford University's Nuffield Department of Medicine release the latest model of a population responding to the coronavirus epidemic. The model - OpenABM-Covid19 - provides public health decision-makers with the ability to review the potential progression and outcome of the coronavirus, including fluctuations in infected individuals, hospitalisations, intensive care unit (ICU) admissions and deaths, and assess the impact of test and trace programmes.

The Vice-Chancellor's Innovation Awards 2020 celebrate research-led innovation at all University levels that is having societal or economic impact. A series of online , being livestreamed throughout September, now offers the opportunity to hear more from each of the Winners, as well as ask questions about their award-winning research. This series will culminate on 7 October in a livestreamed panel discussion, chaired by Professor Chas Bountra, Pro-Vice-Chancellor for Innovation, asking "How do universities deliver economic value?".